Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
In situ forming hydrogel improves RPE cell transplantation in a porcine model
Author Affiliations & Notes
  • Noel Vera
    GelMEDIX, Cambridge, Massachusetts, United States
  • Alex Chen
    GelMEDIX, Cambridge, Massachusetts, United States
  • Max Cotler
    GelMEDIX, Cambridge, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Noel Vera GelMEDIX, Code E (Employment); Alex Chen GelMEDIX, Code E (Employment); Max Cotler GelMEDIX, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1949. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Noel Vera, Alex Chen, Max Cotler; In situ forming hydrogel improves RPE cell transplantation in a porcine model. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1949.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The death of retinal pigment epithelial (RPE) cells in geographic atrophy (GA), a leading cause of blindness with no cure, leads to progressive central vision loss. GelRPE is a cell-laden photo-crosslinkable hydrogel therapy engineered to enable RPE transplantation and restore vision. GelRPE is injected sub-retinally as a liquid and crosslinked in situ into a semisolid gel. GelRPE improves upon existing saline formulations by enhancing injection efficiency and localizing cells at the target site. The advantages of GelRPE subretinal injections compared to standard saline were evaluated in a porcine model.

Methods : Fifteen Yorkshire pigs were segregated into three groups: 2 GelRPE groups (standard and high dose) and a RPE saline injection (standard dose). Eyes were treated in each group with a 50 µL subretinal injection of iPSC-derived RPE using standard cannulas (DORC Subretinal Needle). The GelRPE test articles were injected as a liquid and crosslinked into a semisolid gel after one minute of light exposure using the existing endoilluminator (Alcon Constellation). Ocular exams, optical coherence tomography (OCT), and color fundus imaging were performed throughout the duration of the study with eyes collected for histopathology (H&E) and immunohistochemistry (IHC) at days 1, 5, and 14.

Results : Subretinal injections were successful in creating RPE cell sub-retinal blebs in all subjects. GelRPE test articles were well tolerated. At day 14, viable transplanted cells expressing human-specific antigen (STEM121) and RPE-specific proteins (RPE65, BEST-1, MITF, and ZO-1) were found in all groups. GelRPE formulations transplanted 8.1x more cells per eye on average than saline injections at the same starting dose. Cell morphology in the GelRPE group suggests better attachment and integration to native tissue, including monolayer formation, compared to unattached, hypertrophic cells in saline eyes. More specifically, over 50% of transplanted GelRPE cells exhibited a flat and spread morphology compared to only ~20% of saline RPE cells. Further analysis demonstrated a transplanted RPE to native RPE ratio of > 0.75 in GelRPE groups, significantly higher than that seen with saline (< 0.1), suggesting improvement in transplantation and localization of cells.

Conclusions : GelRPE was able to deliver viable RPE cells and localize them at the target location at a higher number and with better morphology than the saline group.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×